Healthcare
New Japanese VC fund to invest in Europe
Former Mitsui Ventures CEO to lead new firm
Sofinnova-backed Auris announces price range
Float expected to be worth between £69-82m
Shares rise in VC-backed Abzena after £20m IPO
The offering gave Abzena a market cap of £77.9m
Summit picks up August’s Independent Vetcare
Company attracted interest from trade and private equity
Eurazeo takes majority stake in Colisée
Deal values retirement home operator at around €175m
Specialisation sees healthcare investment return to Poland
Enterprise Investors' investment in oncology space reveals interesting development
bm-t invests in Inflarx series-B round
Second of two series-B tranches completed for Jena-based company
Deal in Focus: Doughty sells Quirón to CVC
Doughty reaped 2x money and 40% IRR on Quirón sale to CVC
Inveready leads €600,000 round for Ojer Pharma
Funding will help bring new dermatology products to market
HTGF’s Ayoxxa Biosystems closes €9m series-B
New investors include b-to-v, Creathor and HR Ventures
N+1 et al. sell Xanit Group to Vithas
N+1 backed the business in 2007
MML’s Vanguard in £16.5m refinancing
Deal has freed up capital for investment
VC-backed arGEN-X raises €40m in IPO
Company will list on Euronext Brussels on 10 July
Seventure and LSP invest €4.4m in Mint
Funding round saw participation from existing backers
Equistone backs $100m Concept formation
Investment made from GP's €1.5bn Fund IV
Ardian underwrites €255m facility for Ceva buyout
GP had already backed Ceva in 2007 and 2012
Doughty agrees to sell Quirón to CVC
CVC could merge group with portfolio company Capio
Calculus et al. invest £7.25m in Premaitha
Premaitha has market cap of £19m
Cinven-backed Spire valued at up to £1.1bn for IPO
Firm announces price range with free float of up to 45%
Mid Europa's Alpha Medical bolts on Gendiagnostica
Acquisition extends medical laboratory's CEE services
to-BBB raises €10m series-C
Antea now holds a stake of around 10% in to-BBB
VC-backed Affimed to float
Plans to raise up to $75m in IPO, according to SEC filing
Albion Ventures invests £16m in Berkley-run care homes
Co-operation with Berkley follows similar partnership
VC backers take part in €50m Innate Pharma capital increase
Investors include Wellington Partners, OrbiMed and BPI France